AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+4.75%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.27B
AUM Growth
+$1.27B
(-5%)
Cap. Flow
-$2.92B
Cap. Flow
% of AUM
-229.62%
Top 10 Holdings %
Top 10 Hldgs %
73.65%
Holding
75
New
9
Increased
14
Reduced
10
Closed
15
Top Buys
| 1 |
AerCap
AER
|
$17.2M |
| 2 |
American Airlines Group
AAL
|
$16M |
| 3 |
JMEI
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
|
$11.4M |
| 4 |
LendingClub
LC
|
$8.48M |
| 5 |
Delta Air Lines
DAL
|
$8.22M |
Top Sells
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$2.78B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$49.3M |
| 3 |
BLUE
bluebird bio
BLUE
|
$25.3M |
| 4 |
MetLife
MET
|
$20.2M |
| 5 |
American International
AIG
|
$19.2M |
Sector Composition
| 1 | Healthcare | 62.44% |
| 2 | Consumer Discretionary | 19.3% |
| 3 | Financials | 5.52% |
| 4 | Industrials | 4.15% |
| 5 | Communication Services | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $463M | 19.93% | 57,517,978 -345,107,888 | -86% | -$2.78B |
|
|
WW
2
DELISTED
WW International
WW
| $143M | 6.15% | 29,443,300 | – | – |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $59.5M | 2.56% | 435,000 -45,000 | -9% | -$6.16M |
|
4
Alnylam Pharmaceuticals
ALNY
$58.5B
| $54.5M | 2.35% | 455,000 -15,000 | -3% | -$1.8M |
|
5
Incyte
INCY
$16.5B
| $50M | 2.15% | 480,000 -30,000 | -6% | -$3.13M |
|
6
Alibaba
BABA
$322B
| $41.1M | 1.77% | 500,000 -75,000 | -13% | -$6.17M |
|
7
Mastercard
MA
$538B
| $37.4M | 1.61% | 400,000 +50,000 | +14% | +$4.67M |
|
|
BLUE
8
DELISTED
bluebird bio
BLUE
| $33.7M | 1.45% | 200,000 -150,000 | -43% | -$25.3M |
|
9
Amazon
AMZN
$2.44T
| $28.2M | 1.21% | 65,000 +15,000 | +30% | +$6.51M |
|
|
LNKD
10
DELISTED
LinkedIn Corporation
LNKD
| $27.2M | 1.17% | 131,500 +21,500 | +20% | +$4.44M |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $26.7M | 1.15% | 3,710,000 | – | – |
|
|
MBLY
12
DELISTED
Mobileye N.V.
MBLY
| $26.6M | 1.14% | 500,000 +150,000 | +43% | +$7.98M |
|
|
KITE
13
DELISTED
Kite Pharma, Inc.
KITE
| $25.9M | 1.12% | 425,000 +50,000 | +13% | +$3.05M |
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| $23M | 0.99% | 400,000 | – | – |
|
15
Nektar Therapeutics
NKTR
$568M
| $21.3M | 0.92% | 1,700,000 | – | – |
|
16
Agios Pharmaceuticals
AGIO
$2.19B
| $17.8M | 0.77% | 160,000 +20,000 | +14% | +$2.22M |
|
|
17
AerCap
AER
$22B
| $17.2M | 0.74% | +375,000 | New | +$17.2M |
|
18
Bank of America
BAC
$376B
| $17M | 0.73% | 1,000,000 -200,000 | -17% | -$3.4M |
|
|
19
American Airlines Group
AAL
$8.82B
| $16M | 0.69% | +400,000 | New | +$16M |
|
|
20
LendingClub
LC
$1.97B
| $15.9M | 0.68% | 1,075,000 +575,000 | +115% | +$8.48M |
|
21
Hilton Worldwide
HLT
$64.9B
| $15.2M | 0.65% | 550,000 +250,000 | +83% | +$6.89M |
|
22
General Motors
GM
$55.8B
| $15M | 0.65% | 450,000 +50,000 | +13% | +$1.67M |
|
|
JMEI
23
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $11.4M | 0.49% | +500,000 | New | +$11.4M |
|
|
JUNO
24
DELISTED
Juno Therapeutics, Inc.
JUNO
| $10.1M | 0.44% | 190,000 +60,000 | +46% | +$3.2M |
|
|
25
Delta Air Lines
DAL
$40.3B
| $8.22M | 0.35% | +200,000 | New | +$8.22M |
|